Loopbaan van Daniel-Adriano Silva
Eerdere bekende functies van Daniel-Adriano Silva
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEUROGENE INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2003 | 01-03-2021 |
| Oprichter | 01-12-2003 | 01-03-2021 |
Opleiding van Daniel-Adriano Silva
| Universidad Nacional Autónoma de México | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Mexico | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
